Adcore Inc announced that its Adcore Australia subsidiary has won a contract to manage search engine marketing (SEM) efforts for Australian retailer Best & Less. Best & Less is a retailer of clothing and household linens with 185 stores as well as an online platform, the company noted. “With the COVID-19 pandemic subsiding and brick-and-mortar establishments reopening, retailers are searching for effective strategies to continue to grow their ecommerce success,” Adcore CEO Omri Brill said in a statement.
BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF) said it has entered into an agreement with the Deaconess Research Institute (DRI) to supply it with surgically debulked tumors from Stage III/Stage IV ovarian cancer patients undergoing treatment at Deaconess Health System. The company noted that Evansville, Indiana-based DRI, is the clinical studies arm of Deaconess, a premier regional provider of health care services in the United States. Access to ovarian cancer tumor cells is a critical step enabling it to validate the manufacturing process for BVX-0918, its autologous haptenized tumor cell vaccine for late-stage ovarian cancer, it added. The standard of care for late-stage ovarian cancer often involves surgically debulking of the tumor mass, BioVaxys explained. The debulked tumor cells will be used to test and validate the tumor collection protocol, cryopackaging, cryopreservation, and supply chain logistics for BVX-0918 bioproduction.
ACME Lithium Inc. (CSE:ACME, OTCQB:ACLHF) provided a corporate update on the exploration status of its Clayton Valley, Nevada lithium brine project, as well as its projects in Manitoba and Oregon. The mineral exploration company said it is in the late stages of preparation for a planned multi-hole drill program at its Clayton Valley project, which will focus on the most prospective lithium brine targets as defined by geophysical work completed in the fall of 2021. ACME noted the Nevada project is contiguous to Albemarle's Silver Peak lithium resource and production facility.
Todos Medical Ltd. (OTCQB:TOMDF) has announced that its president and CEO Gerald Commissiong will present at the Emerging Growth Conference on April 27, 2022, from 10.00am-10.45am EST, with registration via the following link: https://goto.webcasts.com/starthere.jsp?ei=1541769&tp_key=abbe1c785f&sti=TOMDF. For more information, investors can visit www.todosmedical.com.
Vuzix Corporation (NASDAQ:VUZI) told investors it will showcase its smart glasses at Field Service Palm Springs 2022 from April 26-28 in Palm Springs, California. The company said it will also support solution partners TeamViewer and Librestream at Field Service, which is attended by a broad list of blue-chip companies that span aerospace/defense, construction, insurance, industrial machinery, medical devices, telecommunications, and utilities, among others. The event targets applications that include customer care and service, field service, global service, service repair, and tech support. Vuzix said it will be located at Kiosk S9 at the JW Marriott in Palm Springs and investors can view its upcoming tradeshow listing by following this link: https://www.vuzix.com/pages/upcoming-events
The company also announced that it will host a conference call regarding its first quarter 2022 operating results on May 10, 2022, at 4:30 PM EDT. Participating on the call will be Vuzix CEO Paul Travers and chief financial officer Grant Russell, who will discuss operational and financial highlights for the quarter ended March 31, 2022. To join the live conference call, please dial 877-709-8150 (US and Canadian callers) or 201-689-8354 (international callers outside of the US and Canada) 10 to 15 minutes before the scheduled call time. Participants can also click this link for instant telephone access to the event. The link will become active approximately 15 minutes before the start of the conference call. Additionally, a live and archived webcast of the conference call will be available on the investor relations page of the company's website at: https://ir.vuzix.com/ or directly at https://event.choruscall.com/mediaframe/webcast.html?webcastid=Sks0BRX8. Investors who would like to submit questions to management for response during the call's Q&A session, time permitting, can do so by emailing Ed McGregor at ed_mcgregor@vuzix.com before the start of the call. Telephonic and webcast replays will be available for 30 days starting on May 10, 2022 at about 5:30 PM EDT. To access the telephonic replay, please dial 877-660-6853 in the US or Canada and 201-612-7415 for international callers. The conference ID# is 13729447.
Cloud DX (TSX-V:CDX, OTCQB:CDXFF) said it will present at the ONE2ONE Investors Forum, hosted by Proactive Events. One of the five selected companies, Cloud DX noted that the event showcases the ‘best investment opportunities' as selected by Proactive. Attendees can listen to Cloud DX's management discuss the company's story, management, and strategies for the coming year. "Investors, new and experienced alike, can learn about cutting-edge companies and investment opportunities like Cloud DX at this virtual Investor Forum,” the company’s founder and CEO Robert Kaul said. “As a leader in the Virtual Care space, Cloud DX is quickly expanding; our innovative solutions have solved some of the industry's stickiest challenges, a reason both physicians and patients love us.” For a chance to engage directly with its management team and to “get in on the ground floor of a Virtual Care company that is here to stay” Cloud DX said investors can register for the ONE2ONE event by following this link: https://event.webinarjam.com/register/187/lpr1oux3?j=1072133&sfmc_sub=208838054&l=86_HTML&u=62978137&mid=100009383&jb=24
Virtual Investor Conferences (VIC), the leading proprietary investor conference series, in partnership with KCSA Strategic Communications has announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference to be held on April 27-28, 2022. Individual investors, institutional investors, advisors, and analysts are invited to attend this two-day virtual event showcasing live company presentations and interactive discussions focused on psychedelic treatments for mental health disorders and can register via the following link: https://bit.ly/3vcX3BX. There is no cost to log-in, attend live presentations and schedule 1x1 meetings. "As we have seen over the past 18 months, drug development is hard. The good news is many of the companies presenting over the two-day event have shown tremendous clinical progress. I would encourage investors to take a traditional pharma or biotech view of this space and practice patience, do the proper diligence, and the rewards will be tremendous," said Lewis Goldberg, managing partner and founder of KCSA's Psychedelics Practice. "Drug development for mental health care takes time, focus, and is capital intensive. The potential returns remain as dramatic as ever, it's the investors who - to steal a line from Michael Pollan - need to change their minds." Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. To view a complete calendar of Virtual Investor Conferences, investors can visit www.virtualinvestorconferences.com.
Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF) said its subsidiary Medisure has launched a rapid Vitamin D test kit, the first Health Canada-approved at-home testing solution, with sales to begin next month. "The launch and pre-sales of this Vitamin D at-home testing solution is a perfect execution of our vision of being a leading integrated healthcare company," Steven McAuley, chairman and CEO of Empower Clinics said in a statement. "We co-created this product in partnership with pharmacies, who in turn, placed advance orders. We maximized internal synergies by distributing this Medisure product to our The Medi-Collective (TMC) clinics. And we are delivering on our commitment to continually offer convenient, accessible and integrated healthcare solutions - online, in our TMC clinics or in our partner pharmacies - to patients across Canada," McAuley added.
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF)announced that it has formed a special committee to explore advances in digital therapeutics for mental health. The committee will be led by Najla Guthrie, the group's chief executive officer. “We at Wellbeing are excited to form the special committee regarding digital therapeutics to learn more about opportunities that may potentially exist and be worth exploring from a commercial perspective,” Guthrie said in a statement.
ImagineAR Inc. (CSE:IP, OTCQB:IPNFF) has told investors that it is positioned to deliver global immersive augmented reality (AR) mobile engagements for businesses and consumers as the metaverse becomes a key driver of new business opportunities. In a corporate update, the Vancouver-based company said this is especially the case following the launch of its FameDays.com e-greeting hologram platform. “FameDays.com launched on April 15th and we are implementing PR and social media campaigns for targeted events and celebrity promotions,” ImagineAR CEO Alen Paul Silverrstieen said in a statement. “With Tyson Fury's championship win this past weekend, it further positions FameDays.com as one of the market leaders for metaverse fan engagement.”
Steppe Gold Limited (TSX:STGO, OTCQX:STPGF) said it has discovered multiple high-grade zinc zones below gold deposits at its 100%-owned Altan Tsagaan Ovoo (ATO) project in Mongolia. Following exploration drilling at ATO, the Mongolia-focused gold miner said it concentrated on extensional and step-out targets as it maintained activity in late 2021. At the time, it said it continues to ramp up production of gold and silver from the oxide ores at the mine. The results underscore the long-held view that the ATO project has strong long-term potential and remains open to support further drilling targets, the company added.
Dalrada Corporation (OTCQB:DFCO) has reported on the positive results of a second screening study of its patent-pending cerVIA kit used to test for cervical cancer on 100 women in India. The women, aged 31 to 65, were screened with Pap smear and visual inspection with acetic acid (VIA) using the firm's kit and the study revealed VIA's accuracy at 91%. Data from the first cervical cancer clinical study in India revealed that cerVIA had been 96.8% specific. "Innovative tests and healthcare delivery can help restart screening services to reach the goal set by the WHO, to eliminate cervical cancer by 2030," said Dr Payal Keswarpu, Dalrada Health's chief medical officer, who led the study.
Australis Capital Inc (CSE:AUSA, OTCQB:AUSAF) - dba AUDACIOUS - has announced that Mr. Natural, an AUDACIOUS brand, has launched its first product in Nevada, namely the powerful medical oil, Full Spectrum Hash RSO. The high-potency cannabis oil is meant to be ingested orally or applied topically and is named after the Canadian cancer patient Rick Simpson who developed it. Rich in major and minor medicinal cannabinoids, including THC, CBD, and CBN, the oil is known for its potential to provide relief for people suffering from post-traumatic stress disorder (PTSD), chronic illness and pain, the company said. The Mr. Natural brand was developed by US Vietnam Veteran Bob "Natural" Luciano over 50 years ago. Luciano discovered the therapeutic benefits of cannabis during service. Since its founding, Mr. Natural has gained a large following among veterans to help manage symptoms of PTSD and other ailments.
VolitionRx (NYSE-A:VNRX) said its Nu.Q Vet Cancer Test has been launched in Asia through SAGE Healthcare Private Limited, which was appointed as a non-exclusive licensee and distributor for the cancer test last year. Following pre-launch preparations, SAGE hosted a launch event featuring Professor Heather Wilson-Robles, chief medical officer at Volition Veterinary, and Dr Tom Butera, chief executive officer at Volition Veterinary on Friday, April 22. SAGE is now actively marketing the test and will be processing samples and providing test results from its centralized lab with immediate effect. "Over half of the Asian population have a companion animal, with almost a third of households owning a dog. We believe that the opportunity for the Nu.Q Vet Cancer Test is huge,” said Dr Jasmine Kway, chief executive officer of Singapore Volition in a statement.
PlantX Life Inc. (CSE:VEGA) announced that its wholly-owned Portfolio Coffee Inc subsidiary has launched a new Canadian e-commerce platform, which aims to reflect the company's ongoing rebranding efforts in line with its expansion strategy. The plant-based e-commerce platform said the new e-commerce strategy, which offers a user-friendly and interactive online shopping experience, is aimed to forward Portfolio Coffee's mission of helping its customers to (re)discover coffee by offering farm-to-cup fresh, direct-trade coffee sourced from renowned farms around the world and roasted in Canada. “We know from various market research reports that e-commerce website designs are paramount in fostering customer loyalty and boosting brand awareness,” PlantX CEO Lorne Rapkin said in a statement.
LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF) has announced that a corporate veterinary reference laboratory has purchased three MiQLa Systems for one of its many locations. The company’s CEO Dr Jack Regan noted that testing in the veterinary industry is dominated by three corporate companies that have testing locations across the United States. These multi-billion dollar corporations compete against each other for business from veterinary hospitals and clinics that want faster results than the typical 3-5 day wait for culturing bacteria, he added. “In contrast to culture, we are happy to provide the MiQLab System as a rapid two-hour solution for determining whether pathogens are present in a sample and if they harbor drug resistance genes,” Regan said in a statement. “We are confident their experience with our technology will be a good one. Success in this location may result in additional purchases for their other locations and possibly start a wave of adoption in the other corporations as well."
Usha Resources Ltd (TSX-V:USHA) has told investors that the option deal it struck in March this year with Ares Strategic Mining to acquire the Jackpot Lake lithium project in Nevada, USA, has been amended. The drill-ready Jackpot Lake property sits in Clark County, 35 kilometres (km) northeast of Las Vegas, and spans 140 claims for 2,800 acres. Usha said a 5 km by 2 km anomaly has already been successfully delineated within a closed basin that suggests the presence of a highly concentrated lithium brine. Notably, the geology is similar to Albemarle's Silver Peak Nevada lithium mine which has operated continuously since 1966, and Iconic Mineral's Bonnie Claire project, which recently released a preliminary economic assessment (PEA) that indicated a 40-year mine with an after-tax net present value (NPV) of $1.5 billion. Following a preliminary review completed by the TSX Venture Exchange of the option deal, Usha and Ares have agreed to reduce the maximum number of shares to be potentially issued for the second and third payments to 1.875 million from 3 million previously. The consideration for each payment remains the same at $225,000 in cash or shares.
PyroGenesis Canada Inc. (TSX:PYR) has confirmed that the company’s DROSRITE dross recovery technology has been successfully commissioned at Ma’aden Aluminum, a joint venture (JV) with Alcoa, and one of the world’s largest primary aluminum producers with 2021 revenue in excess of US$7 billion. The Montreal-based provider of advanced plasma technologies said the successful milestone involves an initial order for seven DROSRITE systems, the first three of which have passed site acceptance testing and have been fully commissioned, with the remaining four already manufactured and awaiting final shipment at the end user’s request.
American Battery Technology Company said it has appointed Kimberly Eckert, a critical minerals and precious metals strategic financial development expert, as its new chief financial officer. "In order to address the near insatiable demand for low-environmental impact, low-cost, and domestic US-sourced critical battery materials, we have been rapidly accelerating the commercialization of both our lithium-ion battery recycling technologies and our primary lithium and battery metal manufacturing technologies," said Ryan Melsert, CEO and chairman of ABTC in a statement. "We have been performing a rigorous search for a CFO with the specific skill set to support this strategic acceleration, and are beyond excited to announce that Kim has joined our team to lead these strategic finance efforts.”
Vicinity Motor Corp. (TSX-V:VMC) has announced that it will showcase its vehicles in a joint exhibit with its strategic partner EAVX at the Advanced Clean Transportation Expo (ACT Expo) taking place from May 9 to 12, 2022, in Long Beach, California. Billed as North America's largest advanced transportation technology and clean fleet event, the ACT Expo has united the transportation industry in its mission to reduce emissions and build a cleaner, more sustainable tomorrow for more than a decade. Vicinity Motor will jointly exhibit its VMC 1200 Class 3 electric truck with a ProStake Platform Body by Morgan Truck Body, a sister business unit to EAVX, the company said. The unit will be upfitted with its latest VX Control multiplexed technology system, including a 360-degree camera system, digital rearview and side-view mirrors, advanced driver assistance systems and load sensing technology, and will be available at the Ride and Drive portion of the event.
Think Research Corporation (TSX-V:THNK) said it has entered into a credit agreement with Beedie Capital for a non-revolving term convertible loan facility of up to $25 million, including an initial advance of $10 million, to fund acquisitions. "We look forward to having Beedie Capital as a strategic partner supporting our momentum as we execute on our strategy to become an essential data service for clinicians everywhere in the markets we serve,” said Sachin Aggarwal, CEO of Think Research in a statement. “The financing will provide Think with financial flexibility to continue to aggressively grow its services and solutions and to expand its footprint," he added.
Delta 9 Cannabis Inc. (TSX:DN) said it has obtained a loan from a shareholder in the amount of $4,990,264.37 that is due on July 15, 2025. The loan shall bear interest at 6% per annum and is payable monthly.
XPhyto Therapeutics Corp. (CSE:XPHY, OTCQB:XPHYF) said it has closed the final tranche of its private placement, issuing 1.05 million common shares at $1 per share for total gross proceeds of $1.05 million in this final tranche. The company said it will use net proceeds of the placement to facilitate the development and commercialization of its oral and transdermal drug formulations, diagnostic test products, and psychedelic API (active pharmaceutical ingredient) and drug formulations, as well as general working capital purposes. Xphyto paid $84,000 and issued 84,000 share purchase warrants in finders' fees with respect to the final tranche of placement. Each finder's warrant is exercisable into one common share at a price of $1.00 per share for a period of two years from date of issue. All securities issued under the placement will be subject to a regulatory hold period expiring four months from date of issue.
Ximen Mining Corp (TSX-V:XIM, OTCQB:XXMMF) said the TSX Venture Exchange has accepted for filing documentation with respect to the first and second tranches of a non-brokered private placement announced on April 1, 2022, which saw the issue of 8,816,734 shares at a purchase price of 15 cents each, together with 8,816,734 share purchase warrants with an exercise price of 25 cents for a two-year period with 21 placees.
Cloud DX (TSX-V:CDX, OTCQB:CDXFF) said the TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced on April 14, 2022, which will see the issue of 180 unsecured convertible debentures, with each convertible debenture comprising $1,000 principal amount and 1,430 common share purchase warrants of the company with nine placees.
CareRx Corporation (TSX:CRRX) has announced that David Murphy, its president and chief executive officer, has said it will present at the 2022 Bloom Burton & Co. Healthcare Investor Conference, taking place May 2 and 3, 2022, at the Metro Toronto Convention Centre, North Building 255 Front Street West, Toronto. Murphy's presentation is scheduled for Monday, May 2 at 1.30pm ET. A webcast of the presentation will be available in the "Investors" section of CareRx's website at www.carerx.ca on the "Events and Presentations" page. A replay of the presentation will be available on the same page of the website following the event. CareRx management will also be available for one-on-one meetings throughout the day. Investors interested in meeting with CareRx during the conference should contact Bloom Burton & Co.'s conference coordinator.
Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) has announced that Steve Saviuk, its chief executive officer, will present a corporate overview and provide a commercial update on key products of the company at the 2022 Bloom Burton & Co Healthcare Investor Conference on Tuesday, May 3, 2022, at 11.00am ET A live webcast of the presentation may be accessed via https://wsw.com/webcast/bloomburton7/vph/2542156 and on the Webcast & Events page under the Investors section of the company's website at Events - Valeo Pharma. Following the event, an archived webcast will be available on the company's website.
MamaMancini's Holdings, Inc. (OTCQB:MMMB) has announced that its management will participate in the Proactive Investors ONE2ONE Virtual Investor Forum taking place Tuesday, April 26, 2022. Carl Wolf, the company's chief executive officer, is scheduled to present at 2.30pm Eastern (11.30am Pacific) via the following webcast link: https://event.webinarjam.com/register/187/lpr1oux3. A live audio webcast and archive will be available using the same link above. To attend the live virtual investor event, investors can use the webcast link.
Trust Stamp (NASDAQ:IDAI, EURONEXT:AIID) has announced that Josh Allen, its EVP of Corporate Finance will be presenting at The Q2 Investor Summit, hosted by the Investor Summit Group, being held on May 3-4, 2022, at The Westin New York Grand Central, 212 E 42nd St, New York, NY 10017. Allen's presentation will be held on May 4, 2022, at 12.30pm ET via the following webcast link: https://us06web.zoom.us/webinar/register/WN_PI8hL7uISe6T5KTnt9VMU. Allen will also host 1x1 meetings with qualified investors throughout the conference. The conference is completely complimentary to qualified investors, who can register at https://www.meetmax.com/sched/event_83063/investor_reg_new.html?attendee_role_id=ISG_INVESTOR
OTC Markets Group Inc. (OTCQX:OTCM), the operator of regulated markets for 12,000 US and international securities, has announced that DATA Communications Management Corp, a leading provider of marketing and business communications solutions to companies cross North America, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTC Pink market under the symbol DCMDF. Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. "We are pleased to now trade on the OTCQX Market, in addition to the Toronto Stock Exchange," said Richard Kellam, president & chief executive officer of DCM. "We believe that trading on the OTCQX Market will provide enhanced visibility for us in the US public markets as well as improved liquidity for our shareholders."